Right Side Capital Management Research
Investment Thesis
Right Side Capital Management (RSCM) is a quantitative, data-driven Pre-VC-stage venture firm founded in 2012 and based in San Francisco, CA. Their tagline — "A VC with no BS" — reflects a philosophy of radical transparency, fast decisions, and system-based investing rather than gut-feel dealmaking. RSCM targets capital-efficient technology startups that already have revenue-generating products and are raising rounds of $500K or less.
RSCM's core belief is that pattern recognition at scale produces better outcomes than discretionary investing. They gather structured data about a company's history, business model, revenue trajectory, and founder experience, then run it through their proprietary model to make yes/no decisions — typically within one week. There are no mystery gatekeepers: founders know exactly what the firm looks for and exactly where they stand.
Stage Focus
RSCM exclusively targets the Pre-VC (Pre-Seed and Seed) stage — specifically companies with $5K–$30K+ in monthly recurring revenue (MRR) raising at valuations between $1.5M and $4M. They are not growth-stage investors. They invest before most institutional VCs look, which is why they brand themselves as "Pre-VC."
Check Size
RSCM writes $150K–$300K checks into rounds totaling $150K–$500K. In rare exceptions — for companies with exceptional traction — they will participate in rounds up to $1M. They do not lead in the traditional sense but are often the first or catalytic institutional check that enables a round to close.
Sector Focus
RSCM is sector-agnostic in practice but has a demonstrated bias toward:
- B2B SaaS and enterprise software — the largest segment of their 2,000+ portfolio
- Developer tools and infrastructure
- Fintech and payments
- Healthcare technology — growing focus with AI-enabled health companies
- Consumer apps — selective; prioritize apps with strong MRR and low CAC
- Biotech / life sciences — emerging; portfolio includes early biotech plays
- Food, beverage, and agriculture technology — smaller segment
Recent deals show a strong AI/ML tilt: investments in AI agents, AI-powered tax planning, AI voice agents, AI health platforms, and AI-enabled agriculture all appeared in 2025 deal flow.
Geographic Focus
Primarily the United States and Canada. They invest across all US regions; headquarters in San Francisco but not limited to Bay Area.
Decision Process
RSCM uses a three-partner managing director structure (Kevin Dick, Dave Lambert, Jeff Pomeranz). Decisions are made systematically with the aim of providing a yes/no response within one week of receiving a complete application. Founders submit through the RSCM website. There is no warm intro requirement — applications are evaluated on merit and data.
Recent Activity & Fund Status
In June 2025, RSCM closed Fund VI with $55 million in committed capital — their largest fund ever, 50% larger than Fund V. The fund enables them to continue investing in 150+ startups annually. Rolling closes occurred throughout 2024 with the final close on June 9, 2025.
In August 2025, RSCM was named to TIME and Statista's inaugural "America's Top Venture Capital Firms 2025" list, ranking in the top 3% of over 10,000 U.S. VCs evaluated. Criteria included fundraising strength, investment activity, and exit performance.
Recent 2025 investments span: agricultural supply chain (Nuel, $1.9M Pre-Seed, Oct 2025), AI/ML platforms, biotech (Cryton Biosciences), healthcare (Lanyard Health, Dentist Finder), food/beverage (Enliven Foods, BlueHorn Tea), consumer apps (WeBookYou, ShowStop), and enterprise SaaS (Cipher, AgentShop).
Portfolio Highlights
RSCM has invested in 2,000+ companies since 2012, with over 1,000 currently active. Exit track record:
- 5 unicorns in portfolio
- 7 IPOs including DigitalOcean and Compass (NYSE, $6.96B market cap)
- 204 acquisitions
Notable names:
- DigitalOcean — cloud infrastructure platform; IPO (NYSE: DOCN, 2021)
- ClassPass — fitness marketplace; acquired by Mindbody
- Compass — real estate brokerage; IPO (NYSE: COMP, 2021)
- TradingView — financial charting platform; reached unicorn status
- Fireflies — AI meeting transcription
- Gorgias — e-commerce customer support platform
- Seamless AI — B2B contact data
- PetDesk — veterinary practice management
Team
Three Managing Directors co-lead the firm, each with 12+ years at RSCM:
- Kevin Dick (Managing Director) — 20 years in mathematical and data modeling; Founder/CEO of Network Resonance; deep quantitative expertise that underpins RSCM's systematic approach.
- Dave Lambert (Managing Director) — 16 years as CEO/Founder of Acorn Computer and WorkMetro; brings operational founder empathy.
- Jeff Pomeranz (Managing Director) — 20 years in financial services; President/Founder of Hotovec, Pomeranz & Co; LP relations and fund management.
Operations team includes John Eng (Funding Ecosystem Partner, ex-Microsoft/LinkedIn), Paul Swiencicki (Growth Partner, 25 years B2B SaaS sales), Curt Pabst (Venture Partner, 40 years public/private markets), and Samantha Lewis (Head of Marketing, 30+ startup involvements with 2 exits).
Founder Preferences
RSCM looks for post-revenue founders (minimum $5K MRR) who demonstrate capital efficiency — they want founders who know how to make $1 generate more than $1. They value data-driven founders who can articulate metrics clearly. They do not require warm introductions; any founder can apply through their website. The firm has notable diversity metrics: 44% of active portfolio companies have at least one founder of color; 32% have a female or non-binary founder.
Anti-Thesis
RSCM will not invest in:
- Pre-revenue companies (hard requirement: must have paying customers)
- Companies raising more than $500K (rare exceptions for exceptional traction)
- Companies at valuations above $4M at entry
- Businesses that are not capital-efficient by nature
Decision Timeline
Typically one week from receiving a complete application — one of the fastest decision cycles in institutional venture capital.